Ipamorelin explained: growth hormone signalling
A selective secretagogue studied for its focused effect on growth hormone pathways.
Research context
Ipamorelin is a pentapeptide that acts on the ghrelin receptor. Researchers value its selectivity compared with earlier secretagogues.
Reading the evidence
Much of the available literature comes from cell and animal models. Findings should be read with attention to study design, sample size and whether results have been independently replicated.
A note on use
Silsila products are presented for laboratory research only. Nothing in this journal is medical advice, and no product is intended for human or veterinary use.
Sources & evidence
Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers
A dose-escalation study measured growth-hormone release in healthy volunteers; it did not test a CJC-1295 combination.
Read original sourceIpamorelin, the first selective growth hormone secretagogue
The study describes pentapeptide pharmacology and selectivity in experimental models, not broad clinical benefit.
Read original sourceA study indexed in PubMed or hosted on PMC is not NIH or FDA approval. Findings for approved medicines do not establish the safety or effectiveness of Silsila products.